QP Wealth Management
ABVX icon

QP Wealth Management’s Abivax ABVX Stock Holding History

QP Wealth Management’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-3,107
Closed -$414K – 72
2026
Q2 		$414K Buy
+3,107
New +$352K 0.59% 52
2026
Q1 		– Sell
-5,528
Closed -$745K – 67
2025
Q4 		$745K Buy
+5,528
New +$603K 0.66% 37

Other funds holding ABVX

Helikon Investments
Helikon Investments London, United Kingdom $3.52B AUM 36.83% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne Warszawa, Poland $2.08B AUM 157.4% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.6B AUM 33.98% 1-Year Est. Return

QP Wealth Management's ABVX Position: Q3 2026 in Review

QP Wealth Management sold out of Abivax (ABVX) in Q3 2026, closing a stake of 3,107 shares — an estimated $414K sold.

QP Wealth Management first reported a position in ABVX in Q4 2025 and held it in 2 quarters. The position peaked at $745K in Q4 2025. 211 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • QP Wealth Management reported no remaining Abivax position as of Q3 2026 after selling out during the quarter.
  • QP Wealth Management sold 3,107 Abivax shares in Q3 2026, an estimated $414K.
  • QP Wealth Management first reported a position in Abivax in Q4 2025 and held it in 2 quarters.
  • QP Wealth Management's Abivax position peaked at $745K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on QP Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.